Abstract

Identifying microbial pathogens with zoonotic potential in wild-living primates can be important to human health, as evidenced by human immunodeficiency viruses types 1 and 2 (HIV-1 and HIV-2) and Ebola virus. Simian foamy viruses (SFVs) are ancient retroviruses that infect Old and New World monkeys and apes. Although not known to cause disease, these viruses are of public health interest because they have the potential to infect humans and thus provide a more general indication of zoonotic exposure risks. Surprisingly, no information exists concerning the prevalence, geographic distribution, and genetic diversity of SFVs in wild-living monkeys and apes. Here, we report the first comprehensive survey of SFVcpz infection in free-ranging chimpanzees (Pan troglodytes) using newly developed, fecal-based assays. Chimpanzee fecal samples (n = 724) were collected at 25 field sites throughout equatorial Africa and tested for SFVcpz-specific antibodies (n = 706) or viral nucleic acids (n = 392). SFVcpz infection was documented at all field sites, with prevalence rates ranging from 44% to 100%. In two habituated communities, adult chimpanzees had significantly higher SFVcpz infection rates than infants and juveniles, indicating predominantly horizontal rather than vertical transmission routes. Some chimpanzees were co-infected with simian immunodeficiency virus (SIVcpz); however, there was no evidence that SFVcpz and SIVcpz were epidemiologically linked. SFVcpz nucleic acids were recovered from 177 fecal samples, all of which contained SFVcpz RNA and not DNA. Phylogenetic analysis of partial gag (616 bp), pol-RT (717 bp), and pol-IN (425 bp) sequences identified a diverse group of viruses, which could be subdivided into four distinct SFVcpz lineages according to their chimpanzee subspecies of origin. Within these lineages, there was evidence of frequent superinfection and viral recombination. One chimpanzee was infected by a foamy virus from a Cercopithecus monkey species, indicating cross-species transmission of SFVs in the wild. These data indicate that SFVcpz (i) is widely distributed among all chimpanzee subspecies; (ii) is shed in fecal samples as viral RNA; (iii) is transmitted predominantly by horizontal routes; (iv) is prone to superinfection and recombination; (v) has co-evolved with its natural host; and (vi) represents a sensitive marker of population structure that may be useful for chimpanzee taxonomy and conservation strategies.

Highlights

  • Foamy viruses are complex retroviruses that naturally infect numerous mammal species, including primates, felines, bovines and equines, but not humans [1,2,3,4]

  • Our results reveal important new insights into the molecular ecology and natural history of SFVcpz infection that could not have been gained from studies of captive chimpanzees, and show more generally how endangered primates can be studied by non-invasive molecular approaches to elucidate the circumstances and mechanisms of pathogen transmission

  • We examined whether existing methods of SIVcpz fecal antibody and nucleic acid detection [33,37,38] could be adapted to the non-invasive identification and molecular characterization of SFVcpz

Read more

Summary

Introduction

Foamy viruses ( termed spumaviruses) are complex retroviruses that naturally infect numerous mammal species, including primates, felines, bovines and equines, but not humans [1,2,3,4]. Closely related SFVs have been isolated from closely related primate species: a comparison of phylogenies derived from SFV integrase and primate mitochondrial DNA sequences revealed highly congruent relationships, indicating virus-host coevolution for at least 30–40 million years [13]. This ancient relationship may be responsible for the non-pathogenic phenotype of SFV: highly cytopathic in tissue culture, the various SFVs do not seem to cause any recognizable disease in their natural hosts [2,3,14]. Little is known about the prevalence and transmission patterns of SFV in wild-living primate populations

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call